Scythian Biosciences Corp. (TSXV: $SCYB.V) Professional Athlete Advisory Committee Head, NFL Star Bart Oates says, "Company has a winning team"
October 10, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks issues an exclusive podcast interview with NFL Champion Bart Oates, the first appointment of the Scythian Biosciences (TSXV: SCYB) Professional Athlete Advisory Committee.
Oates, a five-time NFL Pro Bowl player and three-time Super Bowl Champion, was announced as the first appointee to the newly formed committee on October 2. Oates identified the strength of the team in all areas as a guide to why Scythian will be successful.
He also shares his personal experiences with concussions in the NFL and his education of the company's treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination and how it can make a difference going forward.
Hear the full podcast:
Interview with Scythian Biosciences (TSXV: $SCYB.V) Bart Oates, 5-time #NFL Pro Bowl Player
Talking about what it takes to be a winner he said "First you look at the team. You look at the dedicated individuals and I think this is a really good team. From a business perspective, financial perspective, from a scientific and medical perspective I think we have a really good team that is dedicated to doing the right thing."
Oates likened Scythian's position to the 1991 New York Giants, with whom he won Super Bowl XXV.
"We weren't the best individuals, but we were the best team and because of that we wound up winning the Super Bowl," he said.
Oates, who received a law degree from Seton Hall University after leaving the NFL, also stressed the importance for other athletes to plan their lives after sports.
"Over 95 percent of the players in the NFL are out of the game and retired by the time they're 30 years old," he said. "So the transition is imperative because it's not a matter of if but when. It's not necessarily about the money, it's about what you're going to do for the rest of your life. I would encourage guys I talk to to really give that thought some consideration. While they're playing, it's a great time during the offseason to really focus, contemplate and position themselves so that they can be prepared for life after football."
About Mr. Oates
A former center for the New York Giants and San Francisco 49ers, Bart Oates is a 5-time NFL Pro Bowl player and a 3-time Super Bowl Champion. Once finished with football, Mr. Oates took law classes and then worked as an attorney, receiving his law degree from Seton Hall University. Mr. Oates maintains an active role in many services to the community, including serving as President of the NY/NJ Chapter of the NFL Alumni Association.
Scythian ( http://scythianbio.com/) is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.
Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities.
Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995.
Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.
About Investorideas.com - News that Inspires Big Ideas
The Investorideas.com podcasts are also available on iTunes, Tunein, Stitcher. Spreaker.com, iHeart.com Radio and Google Play Music.
Visit the Podcast page at Investorideas.com: http://www.investorideas.com/Audio/
Subscribe to Investorideas.com Podcast RSS:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp
Visit Profile page: http://www.investorideas.com/CO/SCYB/